Skip to main content
Top
Published in: Journal of Nuclear Cardiology 4/2016

01-08-2016 | Original Article

Accurate analysis and visualization of cardiac 11C-PIB uptake in amyloidosis with semiautomatic software

Authors: Tanja Kero, MD, Lars Lindsjö, Jens Sörensen, MD, PhD, Mark Lubberink, PhD

Published in: Journal of Nuclear Cardiology | Issue 4/2016

Login to get access

Abstract

Background

11C-PIB PET is a promising non-invasive diagnostic tool for cardiac amyloidosis. Semiautomatic analysis of PET data is now available but it is not known how accurate these methods are for amyloid imaging. The aim of this study was to evaluate the feasibility of one semiautomatic software tool for analysis and visualization of 11C-PIB left ventricular retention index (RI) in cardiac amyloidosis.

Methods and results

Patients with systemic amyloidosis and cardiac involvement (n = 10) and healthy controls (n = 5) were investigated with dynamic 11C-PIB PET. Two observers analyzed the PET studies with semiautomatic software to calculate the left ventricular RI of 11C-PIB and to create parametric images. The mean RI at 15-25 min from the semiautomatic analysis was compared with RI based on manual analysis and showed comparable values (0.056 vs 0.054 min−1 for amyloidosis patients and 0.024 vs 0.025 min−1 in healthy controls; P = .78) and the correlation was excellent (r = 0.98). Inter-reader reproducibility also was excellent (intraclass correlation coefficient, ICC > 0.98). Parametric polarmaps and histograms made visual separation of amyloidosis patients and healthy controls fast and simple.

Conclusion

Accurate semiautomatic analysis of cardiac 11C-PIB RI in amyloidosis patients is feasible. Parametric polarmaps and histograms make visual interpretation fast and simple.
Literature
1.
go back to reference Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med 2003;349:583-96 Epub 2003/08/09.CrossRefPubMed Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med 2003;349:583-96 Epub 2003/08/09.CrossRefPubMed
2.
3.
go back to reference Aprile C, Marinone G, Saponaro R, Bonino C, Merlini G. Cardiac and pleuropulmonary AL amyloid imaging with technetium-99 m labelled aprotinin. Eur J Nucl Med 1995;22:1393-401 Epub 1995/12/01.CrossRefPubMed Aprile C, Marinone G, Saponaro R, Bonino C, Merlini G. Cardiac and pleuropulmonary AL amyloid imaging with technetium-99 m labelled aprotinin. Eur J Nucl Med 1995;22:1393-401 Epub 1995/12/01.CrossRefPubMed
4.
5.
go back to reference Glaudemans AW, Slart RH, Zeebregts CJ, Veltman NC, Tio RA, Hazenberg BP, et al. Nuclear imaging in cardiac amyloidosis. Eur J Nucl Med Mol Imaging 2009;36:702-14 Epub 2009/01/22.CrossRefPubMed Glaudemans AW, Slart RH, Zeebregts CJ, Veltman NC, Tio RA, Hazenberg BP, et al. Nuclear imaging in cardiac amyloidosis. Eur J Nucl Med Mol Imaging 2009;36:702-14 Epub 2009/01/22.CrossRefPubMed
6.
go back to reference Han S, Chong V, Murray T, McDonagh T, Hunter J, Poon FW, et al. Preliminary experience of 99mTc-Aprotinin scintigraphy in amyloidosis. Eur J Haematol 2007;79:494-500 Epub 2007/11/07.CrossRefPubMed Han S, Chong V, Murray T, McDonagh T, Hunter J, Poon FW, et al. Preliminary experience of 99mTc-Aprotinin scintigraphy in amyloidosis. Eur J Haematol 2007;79:494-500 Epub 2007/11/07.CrossRefPubMed
7.
go back to reference Hawkins PN. Serum amyloid P component scintigraphy for diagnosis and monitoring amyloidosis. Curr Opin Nephrol Hypertens 2002;11:649-55 Epub 2002/10/24.CrossRefPubMed Hawkins PN. Serum amyloid P component scintigraphy for diagnosis and monitoring amyloidosis. Curr Opin Nephrol Hypertens 2002;11:649-55 Epub 2002/10/24.CrossRefPubMed
8.
go back to reference Hazenberg BP, van Rijswijk MH, Piers DA, Lub-de Hooge MN, Vellenga E, Haagsma EB, et al. Diagnostic performance of 123I-labeled serum amyloid P component scintigraphy in patients with amyloidosis. Am J Med 2006;119:355 e15-24 Epub 2006/03/28.CrossRefPubMed Hazenberg BP, van Rijswijk MH, Piers DA, Lub-de Hooge MN, Vellenga E, Haagsma EB, et al. Diagnostic performance of 123I-labeled serum amyloid P component scintigraphy in patients with amyloidosis. Am J Med 2006;119:355 e15-24 Epub 2006/03/28.CrossRefPubMed
9.
go back to reference Hongo M, Urushibata K, Kai R, Takahashi W, Koizumi T, Uchikawa S, et al. Iodine-123 metaiodobenzylguanidine scintigraphic analysis of myocardial sympathetic innervation in patients with AL (primary) amyloidosis. Am Heart J 2002;144:122-9 Epub 2002/07/03.CrossRefPubMed Hongo M, Urushibata K, Kai R, Takahashi W, Koizumi T, Uchikawa S, et al. Iodine-123 metaiodobenzylguanidine scintigraphic analysis of myocardial sympathetic innervation in patients with AL (primary) amyloidosis. Am Heart J 2002;144:122-9 Epub 2002/07/03.CrossRefPubMed
10.
go back to reference Liu D, Niemann M, Hu K, Herrmann S, Stork S, Knop S, et al. Echocardiographic evaluation of systolic and diastolic function in patients with cardiac amyloidosis. Am J Cardiol 2011;108:591-8 Epub 2011/08/03.CrossRefPubMed Liu D, Niemann M, Hu K, Herrmann S, Stork S, Knop S, et al. Echocardiographic evaluation of systolic and diastolic function in patients with cardiac amyloidosis. Am J Cardiol 2011;108:591-8 Epub 2011/08/03.CrossRefPubMed
11.
go back to reference Rapezzi C, Quarta CC, Guidalotti PL, Longhi S, Pettinato C, Leone O, et al. Usefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy. Eur J Nucl Med Mol Imaging 2011;38:470-8 Epub 2010/11/12.CrossRefPubMed Rapezzi C, Quarta CC, Guidalotti PL, Longhi S, Pettinato C, Leone O, et al. Usefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy. Eur J Nucl Med Mol Imaging 2011;38:470-8 Epub 2010/11/12.CrossRefPubMed
12.
go back to reference Selvanayagam JB, Hawkins PN, Paul B, Myerson SG, Neubauer S. Evaluation and management of the cardiac amyloidosis. J Am Coll Cardiol 2007;50:2101-10 Epub 2007/11/27.CrossRefPubMed Selvanayagam JB, Hawkins PN, Paul B, Myerson SG, Neubauer S. Evaluation and management of the cardiac amyloidosis. J Am Coll Cardiol 2007;50:2101-10 Epub 2007/11/27.CrossRefPubMed
13.
go back to reference Syed IS, Glockner JF, Feng D, Araoz PA, Martinez MW, Edwards WD, et al. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. JACC Cardiovasc Imaging 2010;3:155-64 Epub 2010/02/18.CrossRefPubMed Syed IS, Glockner JF, Feng D, Araoz PA, Martinez MW, Edwards WD, et al. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. JACC Cardiovasc Imaging 2010;3:155-64 Epub 2010/02/18.CrossRefPubMed
14.
go back to reference Wall JS, Kennel SJ, Stuckey AC, Long MJ, Townsend DW, Smith GT, et al. Radioimmunodetection of amyloid deposits in patients with AL amyloidosis. Blood 2010;116:2241-4 Epub 2010/06/05.CrossRefPubMedPubMedCentral Wall JS, Kennel SJ, Stuckey AC, Long MJ, Townsend DW, Smith GT, et al. Radioimmunodetection of amyloid deposits in patients with AL amyloidosis. Blood 2010;116:2241-4 Epub 2010/06/05.CrossRefPubMedPubMedCentral
15.
go back to reference Mongeon FP, Jerosch-Herold M, Coelho-Filho OR, Blankstein R, Falk RH, Kwong RY. Quantification of extracellular matrix expansion by CMR in infiltrative heart disease. JACC Cardiovasc Imaging 2012;5:897-907 Epub 2012/09/15.CrossRefPubMedPubMedCentral Mongeon FP, Jerosch-Herold M, Coelho-Filho OR, Blankstein R, Falk RH, Kwong RY. Quantification of extracellular matrix expansion by CMR in infiltrative heart disease. JACC Cardiovasc Imaging 2012;5:897-907 Epub 2012/09/15.CrossRefPubMedPubMedCentral
16.
go back to reference Banypersad SM, Sado DM, Flett AS, Gibbs SD, Pinney JH, Maestrini V, et al. Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study. Circ Cardiovasc Imaging 2013;6:34-9 Epub 2012/11/30.CrossRefPubMed Banypersad SM, Sado DM, Flett AS, Gibbs SD, Pinney JH, Maestrini V, et al. Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study. Circ Cardiovasc Imaging 2013;6:34-9 Epub 2012/11/30.CrossRefPubMed
17.
go back to reference Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, et al. Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B. Ann Neurol 2004;55:306-19 Epub 2004/03/03.CrossRefPubMed Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, et al. Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B. Ann Neurol 2004;55:306-19 Epub 2004/03/03.CrossRefPubMed
18.
go back to reference Antoni G, Lubberink M, Estrada S, Axelsson J, Carlson K, Lindsjo L, et al. In vivo visualization of amyloid deposits in the heart with 11C-PIB and PET. J Nucl Med 2013;54:213-20 Epub 2012/12/15.CrossRefPubMed Antoni G, Lubberink M, Estrada S, Axelsson J, Carlson K, Lindsjo L, et al. In vivo visualization of amyloid deposits in the heart with 11C-PIB and PET. J Nucl Med 2013;54:213-20 Epub 2012/12/15.CrossRefPubMed
19.
go back to reference Dorbala S, Vangala D, Semer J, Strader C, Bruyere JR Jr, Di Carli MF, et al. Imaging cardiac amyloidosis: a pilot study using (1)(8)F-florbetapir positron emission tomography. Eur J Nucl Med Mol Imaging 2014;41:1652-62 Epub 2014/05/21.CrossRefPubMed Dorbala S, Vangala D, Semer J, Strader C, Bruyere JR Jr, Di Carli MF, et al. Imaging cardiac amyloidosis: a pilot study using (1)(8)F-florbetapir positron emission tomography. Eur J Nucl Med Mol Imaging 2014;41:1652-62 Epub 2014/05/21.CrossRefPubMed
20.
go back to reference Furukawa K, Ikeda S, Okamura N, Tashiro M, Tomita N, Furumoto S, et al. Cardiac positron-emission tomography images with an amyloid-specific tracer in familial transthyretin-related systemic amyloidosis. Circulation 2012;125:556-7 Epub 2012/01/25.CrossRefPubMed Furukawa K, Ikeda S, Okamura N, Tashiro M, Tomita N, Furumoto S, et al. Cardiac positron-emission tomography images with an amyloid-specific tracer in familial transthyretin-related systemic amyloidosis. Circulation 2012;125:556-7 Epub 2012/01/25.CrossRefPubMed
21.
go back to reference Nesterov SV, Han C, Maki M, Kajander S, Naum AG, Helenius H, et al. Myocardial perfusion quantitation with 15O-labelled water PET: high reproducibility of the new cardiac analysis software (Carimas). Eur J Nucl Med Mol Imaging 2009;36:1594-602 Epub 2009/05/02.CrossRefPubMed Nesterov SV, Han C, Maki M, Kajander S, Naum AG, Helenius H, et al. Myocardial perfusion quantitation with 15O-labelled water PET: high reproducibility of the new cardiac analysis software (Carimas). Eur J Nucl Med Mol Imaging 2009;36:1594-602 Epub 2009/05/02.CrossRefPubMed
22.
go back to reference Thie JA. Clarification of a fractional uptake concept. J Nucl Med 1995;36:711-2 Epub 1995/04/01.PubMed Thie JA. Clarification of a fractional uptake concept. J Nucl Med 1995;36:711-2 Epub 1995/04/01.PubMed
23.
go back to reference Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Int J Cardiovasc Imaging 2002;18:539-42 Epub 2002/07/24.PubMed Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Int J Cardiovasc Imaging 2002;18:539-42 Epub 2002/07/24.PubMed
24.
go back to reference Zhang S, Smailagic N, Hyde C, Noel-Storr AH, Takwoingi Y, McShane R, et al. (11)C-PIB-PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev. 2014;7:CD010386 Epub 2014/07/24.PubMed Zhang S, Smailagic N, Hyde C, Noel-Storr AH, Takwoingi Y, McShane R, et al. (11)C-PIB-PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev. 2014;7:CD010386 Epub 2014/07/24.PubMed
Metadata
Title
Accurate analysis and visualization of cardiac 11C-PIB uptake in amyloidosis with semiautomatic software
Authors
Tanja Kero, MD
Lars Lindsjö
Jens Sörensen, MD, PhD
Mark Lubberink, PhD
Publication date
01-08-2016
Publisher
Springer US
Published in
Journal of Nuclear Cardiology / Issue 4/2016
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-015-0149-9

Other articles of this Issue 4/2016

Journal of Nuclear Cardiology 4/2016 Go to the issue